J&J | JNJ - Capitalização De Mercado





Capitalização De Mercado Alterar Data
AbbVie USD 435.86B 8.73B 2026-08
Abbott USD 158.05B 20.36B 2026-06
Amgen USD 209.65B 14.21B 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
Baxter International USD 11.01B 2.34B 2026-06
Bayer EUR 49.51B 10.82B 2026-08
Becton, Dickinson and Co. USD 51.35B 9.65B 2026-08
Biogen USD 31.9B 5B 2026-06
Boston Scientific USD 63.44B 29.82B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Cooper Companies USD 12.27B 3.68B 2026-03
Dexcom USD 25.99B 1.82B 2026-06
Edwards Lifesciences USD 52.09B 5.92B 2026-06
Eli Lilly USD 1.11T 18.32B 2026-08
Gilead Sciences USD 168.68B 11.82B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Globus Medical USD 10.98B 251M 2026-08
Insulet USD 9.32B 1.23B 2026-08
Integra LifeSciences USD 1.4B 664M 2026-06
Intuitive Surgical USD 140.84B 22.89B 2026-06
J&J USD 611.36B 32.21B 2026-06
Merck USD 324.18B 6.81B 2026-08
Merit Medical Systems USD 4.14B 25M 2026-06
Novartis USD 240.59B 67.17B 2026-06
Pfizer USD 143.89B 5.44B 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Stryker USD 120.7B 5.15B 2026-06
Tandem Diabetes Care USD 1.23B 199M 2026-08
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Vertex Pharmaceuticals USD 121.59B 4.48B 2026-08
Zimmer Biomet Holdings USD 20.17B 3.51B 2026-08
Zoetis USD 35.38B 5.25B 2026-08